ROSELLE YU-ISIDERIO: Open Payments
NPI 1871241067 · ZION, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,042 in 26 payments from 16 companies in 2025. Trend: 2023 $145 · 2024 $1,358 · 2025 $1,042
Food & beverage: $853Education: $189
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $202 |
| Syndax Pharmaceuticals, Inc. | 4 | $162 |
| Incyte Corporation | 2 | $141 |
| SEAGEN INC. | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| BeOne Medicines USA, Inc. | 3 | $76 |
| Celgene Corporation | 2 | $52 |
| PharmaEssentia USA Corporation | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| GENZYME CORPORATION | 1 | $28 |
Products named: Xospata, Jakafi, SARCLISA, BRUKINSA, REBLOZYL, Cresemba, BESREMI, CALQUENCE.
Industry payments across IL — which companies pay providers there.
